Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Pankert

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Annales De Cardiologie Et D'Angeiologie|September 3, 2023
[Extensive cardiac thombosis in a patient with disseminated intravascular coagulation]Falah Aboukhoudir, Jason Veyrier, Alexandra Dernys, et al.
International Journal of Cardiology|March 12, 2011
Usefulness of index of microcirculatory resistance to detect microvascular dysfunction as a potential mechanism of stress-induced cardiomyopathy (Tako-tsubo syndrome)Thomas Cuisset, Jacques Quilici, Mathieu Pankert, et al.
International Journal of Cardiology|January 21, 2014
Unusual cause of hypoxemia in myocardial infarction: interventional managementMathieu Pankert, Thomas Cuisset, Philippe Aldebert, et al.
International Journal of Cardiology|August 27, 2014
Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrelPierre Deharo, Mathieu Pankert, Guillaume Bonnet, et al.
International Journal of Cardiology|January 21, 2014
Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndromePierre Deharo, Jacques Quilici, Guillaume Bonnet, et al.
Archives of Cardiovascular Diseases|September 28, 2011
Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: the TRASA trialThomas Cuisset, Frederic Franceschi, Sébastien Prevot, et al.
American Heart Journal|May 31, 2020
TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trialMarc Laine, Gilles Lemesle, Stéphane Burtey, et al.
JACC. Cardiovascular Interventions|April 25, 2020
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment: The EARLY Randomized TrialGilles Lemesle, Marc Laine, Mathieu Pankert, et al.
International Journal of Cardiology|March 11, 2015
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitorsPierre Deharo, Mathieu Pankert, Jacques Quilici, et al.
The American Journal of Cardiology|August 30, 2011
Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromeThomas Cuisset, Jacques Quilici, Charlotte Grosdidier, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Annales De Cardiologie Et D'Angeiologie|September 3, 2023
[Extensive cardiac thombosis in a patient with disseminated intravascular coagulation]Falah Aboukhoudir, Jason Veyrier, Alexandra Dernys, et al.
International Journal of Cardiology|March 12, 2011
Usefulness of index of microcirculatory resistance to detect microvascular dysfunction as a potential mechanism of stress-induced cardiomyopathy (Tako-tsubo syndrome)Thomas Cuisset, Jacques Quilici, Mathieu Pankert, et al.
International Journal of Cardiology|January 21, 2014
Unusual cause of hypoxemia in myocardial infarction: interventional managementMathieu Pankert, Thomas Cuisset, Philippe Aldebert, et al.
International Journal of Cardiology|August 27, 2014
Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrelPierre Deharo, Mathieu Pankert, Guillaume Bonnet, et al.
International Journal of Cardiology|January 21, 2014
Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndromePierre Deharo, Jacques Quilici, Guillaume Bonnet, et al.
Archives of Cardiovascular Diseases|September 28, 2011
Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: the TRASA trialThomas Cuisset, Frederic Franceschi, Sébastien Prevot, et al.
American Heart Journal|May 31, 2020
TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trialMarc Laine, Gilles Lemesle, Stéphane Burtey, et al.
JACC. Cardiovascular Interventions|April 25, 2020
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment: The EARLY Randomized TrialGilles Lemesle, Marc Laine, Mathieu Pankert, et al.
International Journal of Cardiology|March 11, 2015
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitorsPierre Deharo, Mathieu Pankert, Jacques Quilici, et al.
The American Journal of Cardiology|August 30, 2011
Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromeThomas Cuisset, Jacques Quilici, Charlotte Grosdidier, et al.
Pageof 4